|
Aug 6
|
Azenta (AZTA) Stock Trades Up, Here Is Why
|
|
Aug 6
|
Azenta Third Quarter 2025 Earnings: EPS: US$0.015 (vs US$0.12 loss in 3Q 2024)
|
|
Aug 5
|
Why Azenta (AZTA) Stock Is Trading Lower Today
|
|
Aug 5
|
Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets
|
|
Aug 5
|
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance
|
|
Aug 4
|
Azenta (AZTA) Q2 Earnings Report Preview: What To Look For
|
|
Jul 31
|
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
|
|
Jul 31
|
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
|
|
Jul 30
|
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
|
|
Jul 25
|
Stocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBC
|
|
Jul 23
|
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast
|
|
Jul 23
|
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know
|
|
Jul 23
|
Stocks making big moves yesterday: Vital Farms, Robinhood, Simmons First National, Medpace, and Azenta
|
|
Jul 22
|
Why Azenta (AZTA) Stock Is Up Today
|
|
Jul 18
|
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
|
|
Jul 18
|
Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
|
|
Jul 17
|
Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks
|
|
May 8
|
Azenta, Inc.'s (NASDAQ:AZTA) Intrinsic Value Is Potentially 44% Above Its Share Price
|
|
May 8
|
Azenta Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 8
|
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ...
|